病毒学报

参考文献

[1]Bhatt S,Gething P W,Brady O J,et al.The global distribution and burden of dengue[J].Nature,2013,496(7446):504-507.

[2]张顺先,王英,闫磊,等.我国2005~2012年登革热流行特征分析[J].中国医药指南,2013(16):401-402.

[3]Chokephaibulkit K,Perng G C.Challenges for the formulation of a universal vaccine against dengue[J].Exp Biol Med(maywood),2013,238(5):566-578.

[4]Miller N.Recent Progress in dengue vaccine research and development[J].Curr Opin Mol Ther,2010,12(1):31-38.

[5]Swaminathan S,Batra G,Khanna N.Dengue vaccines:state of the art[J].Expert Opin Ther Pat,2010,20(6):819-835.

[6]Halstead S B.Identifying Protective dengue vaccines:guide to mastering an empirical process[J].Vaccine,2013,31(41):4501-4507.

[7]Wallis T P,Huang C Y,Nimkar S B,et al.Determination of the disulfide bond arrangement of dengue virus NS1protein[J].J Biol Chem,2004,279(20):20729-20741.

[8]Edeling M A,Diamond M S,Fremont D H.Structural basis of flavivirus ns1assembly and antibody recognition[J].Proc Natl Acad Sci U S A,2014,111(11):4285-4290.

[9]Muller D A,Young P R.The flavivirus NS1protein:molecular and structural biology,immunology,role in pathogenesis and application as a diagnostic biomarker[J].Antiviral Res,2013,98(2):192-208.

[10]Akey D L,Brown W C,Dutta S,et al.Flavivirus NS1structures reveal surfaces for associations with membranes and the Immune system[J].Science,2014,343(6173):881-885.

[11]Young P R,Hilditch P A,Bletchly C,et al.An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1in the sera of infected patients[J].J Clin Microbiol,2000,38(3):1053-1057.

[12]Alcon S,Talarmin A,Debruyne M,et al.Enzymelinked immunosorbent assay specific to dengue virus type 1nonstructural protein NS1reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections[J].J Clin Microbiol,2002,40(2):376-381.

[13]Wan S W,Lu Y T,Huang C H,et al.Protection against dengue virus infection in mice by administration of antibodies against modified nonstructural protein 1[J/OL].PLoS One,2014,9(3):e92495.

[14]Amorim J H,Diniz M O,Cariri F A,et al.Protective immunity to DENV-2after Immunization with a recombinant NS1protein using agenetically detoxified heatlabile toxin as an adjuvant[J].Vaccine,2012,30(5):837-845.

[15]Huang S S,Li I H,Hong P D,et al.Evaluation of protective efficacy using a nonstructural protein NS1in DNA vaccine-loaded microspheres against dengue 2virus[J].Int J Nanomedicine,2013,8:3161-3169.

[16]Henchal E A,Henchal L S,Schlesinger J J.Synergistic interactions of anti-NS1 Monoclonal antibodies protect passively immunized mice from lethal challenge with dengue 2virus[J].J Gen Virol,1988,69(Pt 8):2101-2107.

[17]Wan S W,Lin C F,Yeh T M,et al.Autoimmunity in dengue pathogenesis[J].J Formos Med Assoc,2013,112(1):3-11.

[18]Costa S M,Azevedo A S,Paes M V,et al.DNA vaccines against dengue virus based on the NS1gene:the influence of different signal sequences on the protein expression and its correlation to the immune response elicited in mice[J].Virology,2007,358(2):413-423.

[19]Henriques H R,Rampazo E V,Goncalves A J,et al.Targeting the non-structural protein 1from dengue virus to a dendritic cell population confers protective Immunity to Lethal Virus Challenge[J/OL].PLoS Negl Trop Dis,2013,7(7):e2330.

[20]Volpina O M,Volkova T D,Koroev D O,et al.A synthetic peptide based on the NS1non-structural protein of tick-borne encephalitis virus induces a protective immune response against fatal encephalitis in anexperimental animal model[J].Virus Res,2005,112(1):95-99.

[21]Shresta S.Role of complement in dengue virus infection:protection or pathogenesis?[J/OL].MBIO,2012,3(1):e00003-12.

[22]Silva E M,Conde J N,Allonso D,et al.Mapping the interactions of dengue virus NS1protein with human liver proteins using ayeast two-hybrid system:identification of C1q as an interacting partner[J/OL].PLoS One,2013,8(3):e57514.

[23]Avirutnan P,Zhang L,Punyadee N,et al.Secreted NS1of dengue virus attaches to the surface of cells via interactions with heparan sulfate and chondroitin sulfate E[J/OL].PLoS Pathog,2007,3(11):e183.

[24]Lin S W,Chuang Y C,Lin Y S,et al.Dengue virus nonstructural protein NS1 binds to prothrombin/thrombin and inhibits prothrombin activation[J].J Infect,2012,64(3):325-334.

[25]Chua J J,Bhuvanakantham R,Chow V T,et al.Recombinant non-structural 1(NS1)protein of dengue-2virus interacts with human stat3beta protein[J].Virus Res,2005,112(1):85-94.

[26]Avirutnan P,Fuchs A,Hauhart R E,et al.Antagonism of the complement component C4 by flavivirus nonstructural protein NS1[J].J Exp Med,2010,207(4):793-806.

[27]Avirutnan P,Hauhart R E,Marovich M A,et al.Complement-mediated neutralization of dengue virus requires mannose-binding lectin[J/OL].MBIO,2011,2(6):e00276-11.

[28]Avirutnan P,Punyadee N,Noisakran S,et al.Vascular leakage in severe dengue virus infections:apotential role for the nonstructural viral protein NS1and complement[J].J Infect Dis,2006,193(8):1078-1088.

[29]Libraty D H,Young P R,Pickering D,et al.High circulating levels of the dengue virus nonstructural protein NS1early in dengue illness correlate with the development of dengue hemorrhagic fever[J].J Infect Dis,2002,186(8):1165-1168.

[30]Falconar A K,Martinez F.The NS1glycoprotein can generate dramatic antibody-enhanced dengue viral replication in normal out-bred mice resulting in lethal multiorgan disease[J/OL].PLoS One,2011,6(6):e21024.

[31]Kurosu T,Chaichana P,Yamate M,et al.Secreted complement regulatory protein clusterin interacts with dengue virus nonstructural protein 1[J].Biochem Biophys Res Commun,2007,362(4):1051-1056.

[32]Immenschuh S,Rahayu P,Bayat B,et al.Antibodies against dengue virus nonstructural protein-1 induce heme oxygenase-1 via a redox-dependent pathway in human endothelial cells[J].Free Radic Biol Med,2013,54:85-92.

[33]Amorim J H,Pereira bizerra R S,Dos santos alves R P,et al.A genetic and pathologic study of a denv2clinical isolate capable of inducing encephalitis and hematological disturbances in immunocompetent mice[J/OL].PLoS One,2012,7(9):e44984.

[34]Lin C F,Lei H Y,Liu C C,et al.Generation of IgM anti-platelet autoantibody in dengue patients[J].J Med Virol,2001,63(2):143-149.

[35]Lin C F,Lei H Y,Shiau A L,et al.Antibodies from dengue patient sera cross-react with endothelial cells and induce damage[J].J Med Virol,2003,69(1):82-90.

[36]Falconar A K.The dengue virus nonstructural-1protein(NS1)generates antibodies to common epitopes on human blood clotting,integrin/adhesin proteins and binds to human endothelial cells:potential implications in haemorrhagic fever pathogenesis[J].Arch Virol,1997,142(5):897-916.

[37]Lin C F,Lei H Y,Shiau A L,et al.Endothelial Cell Apoptosis induced by antibodies against dengue virus nonstructural protein 1via production of nitric oxide[J].J Immunol,2002,169(2):657-664.

[38]Falconar A K.Antibody responses are generated to immunodominant ELK/KLE-type motifs on the nonstructural-1glycoprotein during live dengue virus infections in mice and humans:implications for diagnosis,pathogenesis,and vaccine design[J].Clin Vaccine Immunol,2007,14(5):493-504.

[39]SunD S,King C C,Huang H S,et al.Antiplatelet autoantibodies elicited by dengue virus non-structural protein 1cause thrombocytopenia and mortality in mice[J].J Thromb Haemost,2007,5(11):2291-2299.

[40]Chen L C,Lin C F,Wan S W,et al.Anti-dengue virus nonstructural protein 1 antibodies cause no-mediated endothelial cell apoptosis via ceramide-regulated glycogen synthase kinase-3beta and nf-kappab activation[J].J Immunol,2013,191(4):1744-1752.

[41]Chen L C,Shyu H W,Lin H M,et al.Dengue virus induces thrombomodulin expression in human endothelial cells and monocytes in vitro[J].J Infect,2009,58(5):368-374.

[42]Chen M C,Lin C F,Lei H Y,et al.Deletion of the Cterminal region of dengue virus nonstructural protein 1(NS1)abolishes anti-NS1-mediated platelet dysfunction and bleeding tendency[J].J Immunol,2009,183(3):1797-1803.

[43]Rajapakse S.Dengue shock[J].J Emerg Trauma Shock,2011,4(1):120-127.

[44]WHO.Dengue and dengue haemorrhagic fever,2009.